Fresenius Medical Care Corporation (FMS)

NYSE
Currency in USD
24.46
+0.29(+1.20%)
Closed·
After Hours
24.96+0.50(+2.04%)
·
FMS Scorecard
Full Analysis
High shareholder yield
Earnings results expected in 9 days
Fair Value
Day's Range
24.2424.47
52 wk Range
17.9325.96
Key Statistics
Edit
Prev. Close
24.17
Open
24.4
Day's Range
24.24-24.47
52 wk Range
17.93-25.96
Volume
249.6K
Average Volume (3m)
347.46K
1-Year Change
21.69%
Book Value / Share
51.47
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FMS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
27.22
Upside
+11.27%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield
Show more

Fresenius Medical Care Corporation Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, physician nephrology, ambulant treatment, and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Compare FMS to Peers and Sector

Metrics to compare
FMS
Peers
Sector
Relationship
P/E Ratio
23.4x18.4x−0.5x
PEG Ratio
3.060.120.00
Price/Book
0.9x1.7x2.6x
Price / LTM Sales
0.7x1.0x2.9x
Upside (Analyst Target)
12.9%62.1%60.5%
Fair Value Upside
Unlock23.3%8.5%Unlock

Analyst Ratings

2 Buy
3 Hold
1 Sell
Ratings:
6 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 27.22
(+11.27% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.83%
Dividend Yield
1.81%
Industry Median 1.55%
Annualized payout
0.44
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Feb 25, 2025
EPS / Forecast
0.23 / 0.49
Revenue / Forecast
5.09B / 6.02B
EPS Revisions
Last 90 days

People Also Watch

25.94
SILA
-1.07%
9.480
VIV
-0.63%
18.68
KT
-0.16%
14.230
BBVA
+1.07%
72.18
CMS
-2.64%

FAQ

What Is the Fresenius Medical Care ADR (FMS) Stock Price Today?

The Fresenius Medical Care ADR stock price today is 24.46

What Stock Exchange Does Fresenius Medical Care ADR Trade On?

Fresenius Medical Care ADR is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Fresenius Medical Care ADR?

The stock symbol for Fresenius Medical Care ADR is "FMS."

Does Fresenius Medical Care ADR Pay Dividends? What’s The Current Dividend Yield?

The Fresenius Medical Care ADR dividend yield is 1.81%.

What Is the Fresenius Medical Care ADR Market Cap?

As of today, Fresenius Medical Care ADR market cap is 14.30B.

What is Fresenius Medical Care ADR Earnings Per Share?

The Fresenius Medical Care ADR EPS is 1.83.

What Is the Next Fresenius Medical Care ADR Earnings Date?

Fresenius Medical Care ADR will release its next earnings report on May 06, 2025.

From a Technical Analysis Perspective, Is FMS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.